These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 27838535)
1. Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis. Isrow D; Burmeister C; Hanna RK; Elshaikh MA Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():115-120. PubMed ID: 27838535 [TBL] [Abstract][Full Text] [Related]
2. Is Older Age a Real Adverse Prognostic Factor in Women With Early-Stage Endometrial Carcinoma? A Matched Analysis. Haley L; Burmeister C; Buekers T; Elshaikh MA Int J Gynecol Cancer; 2017 Mar; 27(3):479-485. PubMed ID: 28060139 [TBL] [Abstract][Full Text] [Related]
3. The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis. Ghanem AI; Khan NT; Mahan M; Ibrahim A; Buekers T; Elshaikh MA Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():225-230. PubMed ID: 28068595 [TBL] [Abstract][Full Text] [Related]
4. Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study. Elshaikh MA; Al-Wahab Z; Mahdi H; Albuquerque K; Mahan M; Kehoe SM; Ali-Fehmi R; Rose PG; Munkarah AR Gynecol Oncol; 2015 Feb; 136(2):235-9. PubMed ID: 25511158 [TBL] [Abstract][Full Text] [Related]
5. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma. Elshaikh MA; Vance S; Suri JS; Mahan M; Munkarah A Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):351-6. PubMed ID: 24411608 [TBL] [Abstract][Full Text] [Related]
6. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome. Gayar OH; Robbins JR; Parikh K; Lu M; Buekers T; Munkarah A; Elshaikh MA Gynecol Oncol; 2011 Oct; 123(1):71-5. PubMed ID: 21767871 [TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma. Bhatnagar AR; Ghanem AI; Alkamachi B; Allo G; Lin CH; Hijaz M; Elshaikh MA Gynecol Oncol; 2024 Sep; 188():44-51. PubMed ID: 38936280 [TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study. Fu HC; Chen JR; Chen MY; Hsu KF; Cheng WF; Chiang AJ; Ke YM; Chen YC; Chang YY; Huang CY; Kang CY; Kan YY; Hsiao SM; Yen MS J Gynecol Oncol; 2018 Sep; 29(5):e76. PubMed ID: 30022636 [TBL] [Abstract][Full Text] [Related]
9. Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement. Zaki MA; Robbins JR; Fatteh S; Mahan MG; Hanna RK; Elshaikh MA Anticancer Res; 2012 Sep; 32(9):4061-5. PubMed ID: 22993361 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma. Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535 [TBL] [Abstract][Full Text] [Related]
11. The impact of tumor grade on survival end points and patterns of recurrence of 949 patients with early-stage endometrioid carcinoma: a single institution study. Gayar OH; Patel S; Schultz D; Mahan M; Rasool N; Elshaikh MA Int J Gynecol Cancer; 2014 Jan; 24(1):97-101. PubMed ID: 24264358 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study. Zhu J; Wen H; Bi R; Wu X J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439 [TBL] [Abstract][Full Text] [Related]
13. A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer. Feldman A; Chaugle S; Burmeister C; Munkarah A; Elshaikh MA Gynecol Obstet Invest; 2019; 84(3):283-289. PubMed ID: 30540995 [TBL] [Abstract][Full Text] [Related]
14. Does Age-Adjusted Charlson Comorbidity Score Impact Survival Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer? Ghanem AI; Modh A; Burmeister C; Munkarah AR; Elshaikh MA Gynecol Obstet Invest; 2018; 83(3):290-298. PubMed ID: 29518778 [TBL] [Abstract][Full Text] [Related]
15. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer. Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607 [TBL] [Abstract][Full Text] [Related]
16. Predictors of Survival After Recurrence in Women With Early-Stage Endometrial Carcinoma. Xu Y; Burmeister C; Hanna RK; Munkarah A; Elshaikh MA Int J Gynecol Cancer; 2016 Jul; 26(6):1137-42. PubMed ID: 27206283 [TBL] [Abstract][Full Text] [Related]
17. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer. Robbins JR; Gayar OH; Zaki M; Mahan M; Buekers T; Elshaikh MA Gynecol Oncol; 2013 Dec; 131(3):593-7. PubMed ID: 24125752 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus. Onstad M; Ducie J; Fellman BM; Abu-Rustum NR; Leitao M; Mariani A; Multinu F; Lu KH; Soliman P Int J Gynecol Cancer; 2020 Apr; 30(4):485-490. PubMed ID: 31980487 [TBL] [Abstract][Full Text] [Related]